Figure 2
Figure 2. Points of potential disruption of vitamin K cycle and potentiation of warfarin effect by NAPQ1 and ONOO−. NAD(P)H indicates reduced nicotinamide adenine dinucleotide phosphate; NAD(P)+, oxidized nicotinamide adenine dinucleotide phosphate; ONOO−, peroxynitrite; and SH, sulfhydryl group.

Points of potential disruption of vitamin K cycle and potentiation of warfarin effect by NAPQ1 and ONOO−. NAD(P)H indicates reduced nicotinamide adenine dinucleotide phosphate; NAD(P)+, oxidized nicotinamide adenine dinucleotide phosphate; ONOO−, peroxynitrite; and SH, sulfhydryl group.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal